Netherlands· NL-bf2d2e900fbd
Pomalidomide Viatris 2 mg harde capsules
A pomalidomide product containing pomalidomide, registered in Netherlands by Viatris Limited. The same ATC class is registered in 17 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Pomalidomide is registered in 17 of 19 countries.
Countries holding a registration under ATC L04AX06 (pomalidomide), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 9 of them publish a price we can compare per daily dose
Pomalidomide · ATC L04AX06
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of pomalidomide costs, country by country.
Normalised to the WHO defined daily dose (3 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Pomalidomide · price per daily dose (3 mg)
USD · FX 28 Sept 2026
- CH Switzerland$255.48
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- POMALIDOMIDE
- Manufacturer
- Viatris Limited
- Country
- Netherlands (NL)
- ATC code
- L04AX06
- ATC class
- Pomalidomide
- Defined daily dose
- 3 mg, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/23/1785
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
277 interactions on record for pomalidomide.
Graded by severity as the source publishes them — 64 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Pomalidomide · interactions on record
277 records
- 64 severe
- 213 moderate
Most severe, free to view
- ErythropoietinB03XA01severe
- Darbepoetin alfaB03XA02severe
- PeginesatideB03XA04severe
- C1-inhibitor, plasma derivedB06AC01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Pomalidomide in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaIMNOVIDBristol-Myers Squibb Pharma EEIG, Dublin
- SwedenDavunfite 2 mg Kapsel, hårdDay Zero ehf
- SwitzerlandImnovid
- United StatespomalidomideNovadoz Pharmaceuticals LLC
- PolandImnovidBristol-Myers Squibb Pharma EEIG
- FinlandImnovidBristol-Myers Squibb Pharma EEIG
- SpainIMNOVID 2 MG CAPSULAS DURASBristol-Myers Squibb Pharma Eeig
- United KingdomImnovid 2mg capsulesOriginalis B.V.
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Pomalidomid +pharma, Pomalidomid Devatis
- Belgium · Pomalidomide Eg, Pomalidomide Eugia
- Bulgaria · Помалидомид Devatis, Помалидомид Булгермед
- Cyprus · Pomalidomide, Pomalidomide Adalvo
- Czechia · Pomalidomid Sanexcel, Pomalidomide Abdi
- Germany · Pomadel, Pomalidomid 123 Acurae Pharma
- Denmark · Pomalidomid Devatis, Pomalidomid Grindeks
- Estonia · Pomalidomide Grindeks, Pomalidomide Olpha
- Spain · Pomalidomida Abdi, Pomalidomida Erawya
- Finland · Pomalidomid Avansor, Pomalidomid Devatis
- France · Pomalidomide Eg, Pomalidomide Eugia
- United Kingdom (Northern Ireland) · Pomalidomide, Pomalidomide Amarox
- Greece · Polidma, Pomalidomide Anabiosis
- Hungary · Pomalidomid Onkogen, Pomalidomide Grindeks
- Ireland · Pomalidomide Clonmel, Pomalidomide Grindeks
- Iceland · Imnovid, Pomalidomide Accord
- Italy · Pomalidomide Abdi, Pomalidomide Aurobindo
- Liechtenstein · Imnovid, Pomalidomide Accord
- Lithuania · Pomalidomide Grindeks, Pomalidomide Olpha
- Luxembourg · Pomalidomide Eg, Pomalidomide Eugia
- Latvia · Pomalidomide Grindeks, Pomalidomide Olpha
- Malta · Pomalidomide, Pomalidomide Clonmel
- Norway · Imnovid, Pomalidomid Devatis
- Poland · Pomalidomid Reig Jofre, Pomalidomide Eugia
- Portugal · Pomalidomida Aurobindo, Pomalidomida Bluepharma
- Romania · Pomalidomidă Dr. Reddy’s, Pomalidomidă Grindeks
- Sweden · Davunfite, Pomalidomid Avansor
- Slovenia · Pomadel, Pomalidomid Grindeks
- Slovakia · Pomalidomid Grindeks, Pomalidomid Stada
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e5ac9d15-8ff1-471c-8e0b-524323bdcc8d GET /v1/drugs/e5ac9d15-8ff1-471c-8e0b-524323bdcc8d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Capsule, hard",
"route": "Oraal gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/pomalidomide-viatris-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Pomalidomide",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp131277",
"excipients": [
"AMMONIA (E 527)",
"CROSCARMELLOSE NATRIUM (E 468)",
"GELATINE (E 441)",
"IJZEROXIDE GEEL (E 172)",
"IJZEROXIDE ROOD (E 172)",
"IJZEROXIDE ZWART (E 172)",
"INDIGOKARMIJN (E 132)",
"MAGNESIUMSTEARAAT (E 470b)",
"MANNITOL (D-) (E 421)",
"PROPYLEENGLYCOL (E 1520)",
"SCHELLAK GLAZE, GEDEELTELIJK VERESTERD",
"SILICIUMDIOXIDE (E 551)",
"TITAANDIOXIDE (E 171)",
"ZETMEEL, GEPREGELATINEERD",
"ZWARTE INKT"
],
"substances": [
"POMALIDOMIDE"
],
"leaflet_url": null,
"authorised_at": "2024/02/29",
"procedure_number": "EMEA/H/C/006195",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/23/1785",
"additional_monitoring": "N"
}See everything about pomalidomide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.